Role of complement component C5 in cerebral ischemia/reperfusion injury

Brain Research

Volumn 1100, Issue 1, 2006, Pages 142-151

  Costa, Cristina ^a,e   Zhao, Limin ^b   Shen, Yamin ^a   Su, Xiao ^a   Hao, Liming ^c   Colgan, Sean P ^d   Stahl, Gregory L ^d   Zhou, Tong ^b   Wang, Yi ^a  

^a ALEXION PHARMACEUTICALS   (United States)

^b University of Alabama at Birmingham   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

Author keywords

Cerebral stroke; Complement component C5; Ischemia reperfusion injury; Middle cerebral artery occlusion

Indexed keywords

COMPLEMENT COMPONENT 5 ANTIBODY; COMPLEMENT COMPONENT C5; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN EDEMA; BRAIN INJURY; BRAIN ISCHEMIA; COMPLEMENT INHIBITION; COMPLEMENT SYSTEM; CONTROLLED STUDY; DISEASE COURSE; IMMUNOPATHOGENESIS; INFLAMMATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOTOR ACTIVITY; MOTOR DYSFUNCTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; REPERFUSION INJURY;

ANIMALS; ANTIBODIES, BLOCKING; ANTIBODIES, MONOCLONAL; BODY TEMPERATURE; BODY WEIGHT; BRAIN EDEMA; BRAIN ISCHEMIA; COMPLEMENT C3-C5 CONVERTASES; COMPLEMENT C5; INFARCTION, MIDDLE CEREBRAL ARTERY; INFLAMMATION MEDIATORS; MALE; MYOCARDIAL INFARCTION; RATS; RATS, WISTAR; REPERFUSION INJURY;

EID: 33746025371     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.05.029     Document Type: Article

References (26)

1. Akita N., Nakase H., Kaido T., Kanemoto Y., and Sakaki T. Protective effect of C1 esterase inhibitor on reperfusion injury in the rat middle cerebral artery occlusion model. Neurosurgery 52 (2003) 395-401
2. Aspey B.S., Taylor F.L., Terruli M., and Harrison M.J. Temporary middle cerebral artery occlusion in the rat: consistent protocol for a model of stroke and reperfusion. Neuropathol. Appl. Neurobiol. 26 (2000) 232-242
3. Barnum S.R., Ames R.S., Maycox P.R., Hadingham S.J., Meakin J., Harrison D., and Parsons A.A. Expression of the complement C3a and C5a receptors after permanent focal ischemia: an alternative interpretation. Glia 38 (2002) 169-173
4. Bhole D., and Stahl G.L. Therapeutic potential of targeting the complement cascade in critical care medicine. Crit. Care Med. 31 (2003) S97-S104
5. Cai S., and Davis III A.E. Complement regulatory protein C1 inhibitor binds to selectins and interferes with endothelial-leukocyte adhesion. J. Immunol. 171 (2003) 4786-4791
6. Carroll M.C. The role of complement and complement receptors in induction and regulation of immunity. Annu. Rev. Immunol. 16 (1998) 545-568
7. Chen H., Chopp M., Zhang Z.G., and Garcia J.H. The effect of hypothermia on transient middle cerebral artery occlusion in the rat. J. Cereb. Blood Flow Metab. 12 (1992) 621-628
8. De Simoni M.G., Storini C., Barba M., Catapano L., Arabia A.M., Rossi E., and Bergamaschini L. Neuroprotection by complement (C1) inhibitor in mouse transient brain ischemia. J. Cereb. Blood Flow Metab. 23 (2003) 232-239
9. De Vries B., Matthijsen R.A., Wolfs T.G., Van Bijnen A.A., Heeringa P., and Buurman W.A. Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation. Transplantation 75 (2003) 375-382
10. Figueroa E., Gordon L.E., Feldhoff P.W., and Lassiter H.A. The administration of cobra venom factor reduces post-ischemic cerebral injury in adult and neonatal rats. Neurosci. Lett. 380 (2005) 48-53
11. Fisher M. Developing therapy for acute ischemic stroke. Therapie 57 (2002) 564-568
12. Furuya K., Takeda H., Azhar S., McCarron R.M., Chen Y., Ruetzler C.A., Wolcott K.M., DeGraba T.J., Rothlein R., Hugli T.E., del Zoppo G.J., and Hallenbeck J.M. Examination of several potential mechanisms for the negative outcome in a clinical stroke trial of enlimomab, a murine anti-human intercellular adhesion molecule-1 antibody: a bedside-to-bench study. Stroke 32 (2001) 2665-2674
13. Ghiran I., Barbashov S.F., Klickstein L.B., Tas S.W., Jensenius J.C., and Nicholson-Weller A. Complement receptor 1/CD35 is a receptor for mannan-binding lectin. J. Exp. Med. 192 (2000) 1797-1808
14. He Z., Yang S.H., Naritomi H., Yamawaki T., Liu Q., King M.A., Day A.L., and Simpkins J.W. Definition of the anterior choroidal artery territory in rats using intraluminal occluding technique. J. Neurol. Sci. 182 (2000) 16-28
15. Heimann A., Takeshima T., Horstick G., and Kempski O. C1-esterase inhibitor reduces infarct volume after cortical vein occlusion. Brain Res. 838 (1999) 210-213
16. Huang J., Kim L.J., Mealey R., Marsh Jr. H.C., Zhang Y., Tenner A.J., Connolly Jr. E.S., and Pinsky D.J. Neuronal protection in stroke by an sLex-glycosylated complement inhibitory protein. Science 285 (1999) 595-599
17. Imm M.D., Feldhoff P.W., Feldhoff R.C., and Lassiter H.A. The administration of complement component C9 augments post-ischemic cerebral infarction volume in neonatal rats. Neurosci. Lett. 325 (2002) 175-178
18. Jiang H., Wagner E., Zhang H., and Frank M.M. Complement 1 inhibitor is a regulator of the alternative complement pathway. J. Exp. Med. 194 (2001) 1609-1616
19. Lindsberg P.J., Ohman J., Lehto T., Karjalainen-Lindsberg M.L., Paetau A., Wuorimaa T., Carpen O., Kaste M., and Meri S. Complement activation in the central nervous system following blood-brain barrier damage in man. Ann. Neurol. 40 (1996) 587-596
20. Liszewski M.K., and Atkinson J. The complement system. In: Paul W.E. (Ed). Fundamental Immunology (1993), Raven Press, New York 917-939
21. Pedersen E.D., Waje-Andreassen U., Vedeler C.A., Aamodt G., and Mollnes T.E. Systemic complement activation following human acute ischemic stroke. Clin. Exp. Immunol. 137 (2004) 117-122
22. Seelen M.A., Roos A., and Daha M.R. Role of complement in innate and autoimmunity. J. Nephrol. 18 (2005) 642-653
23. Stahel P.F., Morganti-Kossmann M.C., and Kossmann T. The role of the complement system in traumatic brain injury. Brain Res. Rev. 27 (1998) 243-256
24. Vakeva A.P., Agah A., Rollins S.A., Matis L.A., Li L., and Stahl G.L. Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: role of the terminal complement components and inhibition by anti-C5 therapy. Circulation 97 (1998) 2259-2267
25. Van Beek J., Bernaudin M., Petit E., Gasque P., Nouvelot A., MacKenzie E.T., and Fontaine M. Expression of receptors for complement anaphylatoxins C3a and C5a following permanent focal cerebral ischemia in the mouse. Exp. Neurol. 161 (2000) 373-382
26. Wolf P.A., Clagett G.P., Easton J.D., Goldstein L.B., Gorelick P.B., Kelly-Hayes M., Sacco R.L., and Whisnant J.P. Preventing ischemic stroke in patients with prior stroke and transient ischemic attack: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke 30 (1999) 1991-1994